Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urothelial cells are specialized epithelial cells that comprise the urothelium, a stratified tissue lining the renal pelvis, ureters, urinary bladder, and proximal urethra[1][2][4][7]. The urothelium consists of three cell layers: basal cells (stem/progenitor function), intermediate cells (proliferative/regenerative), and umbrella cells (apical barrier, protection)[4][6][7]. These cells play essential roles in maintaining a highly impermeable barrier to protect underlying tissues from exposure to toxic urine components, accommodate and regulate the bladder's response to volume changes, and activate immune defense mechanisms against pathogens[2][3][4][7]. Urothelial cells are implicated in urinary tract cancers and infections, and serve as critical biomarkers for evaluating urinary tract integrity and disease status[5][7]. The term "Urothelial cells" denotes a cell lineage and is not a molecular drug target such as a receptor, enzyme, or transporter[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urothelial cell.